News

Life Sciences

New Scientific Publication Further Supports BioMark's Assay

New Scientific Publication Further Supports BioMark's Assay

TheNewswire | Equities.com |

Article published in Future Science OA on the predictive value and clinical significance of BioMark's assay.


​Harvard Study Rejuvenates Cannabis’s Potential Role in Cancer Treatment

Stephen L Kanaval | Equities.com |

A recent study shows how cannabis has the potential to kill cancer cells.


BioMark’s Liquid Biopsy Scientific Paper To Be Featured as Cover on Cancers' Upcoming Issue

TheNewswire | Equities.com |

Cancers is an international, peer-reviewed open access journal on oncology.


New Advances in Liquid Biopsy To Increase BioMark's Assay Performance

The Newswire | Equities.com |

Successful pilot study indicates that assay provides specificity required for diagnosing lung cancer.


Verrica (VRCA) Shows Positive Phase 3 Results in Molluscum Contagiosum at AAD Annual Meeting

Edward Kim | Equities.com |

Two Phase 3 trials show positive results in treating this highly contagious skin disease that affects 6 million people in the US, many of whom are children.


Ocular Therapeutix (OCUL) Doses First Patient in Phase 1 Macular Degeneration Trial

Edward Kim | Equities.com |

OCUL testing tyrosine kinase inhibitor implant for wet age-related macular degeneration (AMD)


Stealth BioTherapeutics Raises $78 Million in IPO for Mitochondrial Diseases

Edward Kim | Equities.com |

Dysfunctional mitochondria characterize many rare genetic and common age-related diseases.


On Valentine's Day, We Examine Advances in Heart Research via Data Analytics and AI

Edward Kim | Equities.com |

Advances in genomics, artificial intelligence and software may help predict and reduce cardiovascular risk


Ortho Regenerative Technologies Begins Final Animal Studies in Rotator Cuff Repair

Edward Kim | Equities.com |

Biopolymer designed to increase healing rates of sports related injuries to tendons, meniscus, ligaments and cartilage.


Seres Therapeutics Refocuses Microbiome Pipeline and Cuts Staff

Edward Kim | Equities.com |

Focusing resources on ulcerative colitis, C. difficile infection and a planned immuno-oncology study.


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Jorge Fernandez - iBlades

Equities.com's Sam Mitchell interview iBlades CEO, Jorge Fernandez